Kennedy Capital Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-38,247
Closed -$1.46M 775
2023
Q4
$1.46M Sell
38,247
-725
-2% -$24.1K 0.03% 537
2023
Q3
$1.2M Sell
38,972
-7,889
-17% -$272K 0.03% 545
2023
Q2
$1.48M Sell
46,861
-44,709
-49% -$1.53M 0.03% 510
2023
Q1
$3.34M Buy
91,570
+47,575
+108% +$1.67M 0.1% 332
2022
Q4
$1.3M Sell
43,995
-84
-0.2% -$2.7K 0.04% 458
2022
Q3
$1.72M Buy
+44,079
New +$2.02M 0.05% 436

Other funds holding ASTH

Kennedy Capital Management's ASTH Position: Q1 2024 in Review

Kennedy Capital Management sold out of Astrana Health (ASTH) in Q1 2024, closing a stake of 38,247 shares — an estimated $1.46M sold.

Kennedy Capital Management first reported a position in ASTH in Q3 2022 and held it in 6 quarters. The position peaked at $3.34M in Q1 2023. 159 funds tracked by Wall St. Rank hold ASTH as of Q1 2024.

  • Kennedy Capital Management reported no remaining Astrana Health position as of Q1 2024 after selling out during the quarter.
  • Kennedy Capital Management sold 38,247 Astrana Health shares in Q1 2024, an estimated $1.46M.
  • Kennedy Capital Management first reported a position in Astrana Health in Q3 2022 and held it in 6 quarters.
  • Kennedy Capital Management's Astrana Health position peaked at $3.34M in Q1 2023.
  • 159 funds tracked by Wall St. Rank held Astrana Health as of Q1 2024.

Based on Kennedy Capital Management's 13F filing for Q1 2024, filed 15 May 2024.